FDA Inspection 1223670 — Eisai Company Ltd.

Eisai Company Ltd. — FEI 3004967045

The FDA completed an inspection of Eisai Company Ltd. on Oct 27, 2023 in Kakamigahara. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 27, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kakamigahara (Japan)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
434221 CFR 211.142(b)Storage under appropriate conditions

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.